InflaRx Assessing Feasibility of Broadened Strategy for ANCA‑Associated Vasculitis in Europe Following EMA Recommendation on Tavneos

InflaRx intends to engage with EMA regarding both vilobelimab and izicopan to evaluate the regulatory path to approval in ANCA-associated ...

Uncovering the trigger behind slow earthquakes

New research led by the University of New England's Dr. Timothy Chapman has uncovered the trigger behind slow earthquakes, ...
BioTechniques

Sequencing by synthesis: the story behind its success and tips for the commercialization of academic ideas

We spoke to David Klenerman, co-developer of sequencing by synthesis, to find out how his work heralded the next generation ...

Scientists Discover Hidden Rule That Could Make Fuel Cells Cheaper and More Powerful

A new study reveals that dual-atom catalysts behave in a fundamentally different way than scientists previously thought, challenging a long-standing model used to predict catalytic performance.

Incyte Reports 2023 Second Quarter Financial Results and Provides Updates on Key Clinical Programs

Incyte (Nasdaq:INCY) today reports 2023 second quarter financial results, and provides a status update on the Company's clinical development portfolio. "We delivered ...
NPR

Sources & Methods

National security, unlocked. Each Thursday, host Mary Louise Kelly and a team of NPR correspondents discuss the biggest national security news of the week. With decades of reporting from battlefields ...